Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 546361 - 546380 out of 553687 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L04AB02) infliximab (adm: P) | ZYMFENTRA 120MG/ML INJ,SOLN PEN | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | CelltrionUSA,Inc. |
| USA | (L04AB02) infliximab (adm: P) | ZYMFENTRA 120MG/ML INJ,SOLN PEN | 2 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | CelltrionUSA,Inc. |
| USA | (L04AB02) infliximab (adm: P) | ZYMFENTRA 120MG/ML INJ,SOLN SYR | 2 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | CelltrionUSA,Inc. |
| USA | (L04AB02) infliximab (adm: P) | INFLECTRA 100MG/20ML, INJ | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Spondylitis, Ankylosing;Colitis, Ulcerative;Psoriasis;Crohn Disease;Arthritis, Rheumatoid | PfizerInc. |
| USA | (L04AB02) infliximab (adm: P) | INFLECTRA 100MG/20ML, INJ | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Spondylitis, Ankylosing;Colitis, Ulcerative;Psoriasis;Crohn Disease;Arthritis, Rheumatoid | PfizerInc. |
| USA | (L04AB02) infliximab (adm: P) | REMICADE 100MG/VIL INJ | 1x20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Spondylitis, Ankylosing;Arthritis, Rheumatoid;Psoriasis;Crohn Disease;Arthritis, Psoriatic;Colitis, Ulcerative | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L04AB02) infliximab (adm: P) | REMICADE 100MG/VIL INJ | 1x20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Spondylitis, Ankylosing;Arthritis, Rheumatoid;Psoriasis;Crohn Disease;Arthritis, Psoriatic;Colitis, Ulcerative | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L04AB04) adalimumab (adm: P) | ABRILADA 20MG/0.4ML INJ,SYR | 2X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | PfizerInc. |
| USA | (L04AB04) adalimumab (adm: P) | ABRILADA 20MG/0.4ML INJ,SYR | 2X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | PfizerInc. |
| USA | (L04AB04) adalimumab (adm: P) | ABRILADA 20MG/0.4ML INJ,SYR | 2X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | PfizerInc. |
| USA | (L04AB04) adalimumab (adm: P) | ABRILADA 20MG/0.4ML INJ,SYR | 2X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | PfizerInc. |
| USA | (L04AB04) adalimumab (adm: P) | ABRILADA 40MG/0.8ML INJ,PEN | 0.8ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | PfizerInc. |
| USA | (L04AB04) adalimumab (adm: P) | ABRILADA 40MG/0.8ML INJ,PEN | 0.8ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | PfizerInc. |
| USA | (L04AB04) adalimumab (adm: P) | ABRILADA 40MG/0.8ML INJ,PEN | 2X0.8ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | PfizerInc. |
| USA | (L04AB04) adalimumab (adm: P) | ABRILADA 40MG/0.8ML INJ,PEN | 2X0.8ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | PfizerInc. |
| USA | (L04AB04) adalimumab (adm: P) | ABRILADA 40MG/0.8ML INJ,PEN | 0.8ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | PfizerInc. |
| USA | (L04AB04) adalimumab (adm: P) | ABRILADA 40MG/0.8ML INJ,PEN | 0.8ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | PfizerInc. |
| USA | (L04AB04) adalimumab (adm: P) | ABRILADA 40MG/0.8ML INJ,SYR | 2X0.8ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | PfizerInc. |
| USA | (L04AB04) adalimumab (adm: P) | ABRILADA 40MG/0.8ML INJ,SYR | 2X0.8ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | PfizerInc. |
| USA | (L04AB04) adalimumab (adm: P) | ABRILADA 40MG/0.8ML INJ,SYR | 2X0.8ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | PfizerInc. |
Pages
